EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-cell profiling of HDAC inhibitor-induced EBV lytic heterogeneity defines abortive and refractory states in B lymphoblasts

Lauren E Haynes, Ashley P Barry, Micah A Luftig iD

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1013610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Lauren E Haynes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Duke Center for Virology, Durham, North Carolina, United State…. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Herpesvirus 4, Human, Virus Activation, B-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NCI NIH HHS, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) is associated with multiple malignancies including Burkitt lymphoma (BL), Hodgkin’s lymphomas, nasopharyngeal carcinomas (NPC), and gastric cancers. Canonically, EBV positive tumors display latent gene expression programs that are difficult to target pharmacologically. To overcome this hurdle, lytic reactivation therapies have been developed based on HDAC inhibition with limited mechanistic studies. We therefore characterized the impact of pan-HDAC inhibitor, panobinostat, and class I HDAC inhibitor, nanatinostat, on the growth, survival, and lytic reactivation of four EBV-positive cell lines: P3HR1-ZHT BL, Jijoye BL, IBL-1 immunoblastic lymphoma, and de novo infection derived lymphoblastoid cell lines (LCL). All lines were sensitive, enabling us to define ranges of sensitivity within which to use single cell approaches to assess early EBV lytic gene expression, cell cycle state, and apoptosis. We observed that each EBV-positive model of malignancy responded uniquely to the same HDAC inhibitors and that lytic reactivation was successful in only a small percentage of the cell population. To elucidate the potential role of host factors in preventing successful lytic reactivation, we performed single-cell RNA sequencing on the P3HR1-ZHT BL line treated with the HDAC inhibitor panobinostat. We observed that abortive lytic cells, or cells that do not successfully progress through the lytic cycle, upregulated genes downstream of NF-κB activity. Additionally, genes involved in immune signaling including the CD137/CD137L signaling axis, were upregulated in abortive lytic cells. Functional validation through a Cas9-RNP approach revealed that the CD137 receptor is indeed involved in preventing successful lytic reactivation. These data have important implications for how we approach oncolytic therapies for EBV-associated malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase InhibitorsHerpesvirus 4, HumanVirus ActivationB-LymphocytesEpstein-Barr Virus InfectionsHumansCell Line, TumorPanobinostatSingle-Cell AnalysisApoptosisGene Expression Regulation, Viral

Substanzen

Histone Deacetylase InhibitorsPanobinostat

Autor:innen und Institutionen

  • Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Duke Center for Virology, Durham, North Carolina, United States of America.
  • Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.

ORCID-Profile: Micah A Luftig

Förderung

  • NIDCR NIH HHS
  • NCI NIH HHS
  • National Institute of Dental and Craniofacial Research
  • National Cancer Institute

Zitieren

APA

Haynes, L. E., Barry, A. P., & Luftig, M. A. (2026). Single-cell profiling of HDAC inhibitor-induced EBV lytic heterogeneity defines abortive and refractory states in B lymphoblasts. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013610

Vancouver

Haynes LE, Barry AP, Luftig MA. Single-cell profiling of HDAC inhibitor-induced EBV lytic heterogeneity defines abortive and refractory states in B lymphoblasts. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1013610

BibTeX
@article{Haynes2026,
  author = {Haynes, Lauren E and Barry, Ashley P and Luftig, Micah A},
  title = {Single-cell profiling of HDAC inhibitor-induced EBV lytic heterogeneity defines abortive and refractory states in B lymphoblasts},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1013610}
}
Kostenlos starten →